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Abstract  18 
Redox cycling is an understated mechanism of toxicity associated with a plethora of 19 
xenobiotics, responsible for preventing the effective treatment of serious conditions such as 20 
malaria and cardiomyopathy. Quinone compounds are notorious redox cyclers, present in 21 
drugs such as doxorubicin, which is used to treat a host of human cancers. However, the 22 
therapeutic index of doxorubicin is undermined by dose-dependent cardiotoxicity, which may 23 
be a function of futile redox cycling. In this study, a doxorubicin-specific in silico quinone 24 
redox metabolism model is described. Doxorubicin-GSH adduct formation kinetics are 25 
 2
thermodynamically estimated from its reduction potential, while the remainder of the model 26 
is parameterised using oxygen consumption rate data, indicative of hydroquinone auto-27 
oxidation. The model is then combined with a comprehensive glutathione metabolism model, 28 
facilitating the simulation of quinone redox cycling, and adduct-induced GSH depletion. 29 
Simulations suggest that glutathione pools are most sensitive to exposure duration at 30 
pharmacologically and supra-pharmacologically relevant doxorubicin concentrations. The 31 
model provides an alternative method of investigating and quantifying redox cycling induced 32 
oxidative stress, circumventing the experimental difficulties of measuring and tracking 33 
radical species. This in silico framework provides a platform from which GSH depletion can 34 
be explored as a function of a compound’s physicochemical properties.  35 
 36 
Introduction 37 
Redox cycling describes the continuous reduction and oxidation cycle of a compound, 38 
forming radical intermediates capable of transferring an electron to molecular oxygen, 39 
generating the superoxide radical anion (O2.-) 1. The dismutation of O2.- results in the 40 
formation of hydrogen peroxide (H2O2), which can lead to elevated levels of other potentially 41 
harmful reactive oxygen and nitrogen species (ROS, RNS) 2. Quinone species are arguably 42 
the most renowned redox cyclers and are pivotal to many biological mechanisms 3.  For 43 
example, quinone-based redox cycling facilitates electron transport within the mitochondria 44 
via ubiquinone (Coenzyme Q), and is therefore essential to cellular bioenergetics 4. However, 45 
futile quinone redox cycling can lead to a cascade of ROS formation and as such, the link 46 
between toxicity and quinone redox cycling is widely acknowledged 5. Nevertheless, redox 47 
cycling remains an understated mechanism of toxicity due to the fleeting existence of free 48 
radical intermediates which hinders their quantification in real time, both in vitro and in vivo 49 
6. Potential redox cycling-based toxicity has been implicated with many compounds 7. One 50 
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such quinone containing compound, doxorubicin, is an anthracycline drug used to treat a 51 
variety of human cancers and is regarded as one of the most important chemotherapeutic 52 
agents 8. However, the therapeutic utility of doxorubicin is undermined by its dose-dependent 53 
cardiotoxicity, possibly arising as a result of futile redox cycling, with NADH dehydrogenase 54 
within the mitochondria proposed as the most likely site of anthracycline reduction 9,10.   55 
Cellular glutathione plays a major role in the defence against redox cycling-derived oxidative 56 
stress, either by direct interaction with ROS, RNS and electrophiles, or by acting as a co-57 
factor for various enzymes 11,12. As a result, glutathione is at the forefront of mitigating 58 
quinone-derived toxicity, by enzymatically reducing redox-generated H2O2 to harmless H2O 59 
via glutathione peroxidase, or by direct reaction and detoxification of the quinone 60 
electrophile (Figure 1) 13–15.  61 
 62 
The ability of a quinone to redox cycle is dependent upon the favourability of its reduction by 63 
a single electron, which can be quantitatively described by its reduction potential (ܧ௢). ܧ௢  is 64 
the standard reduction potential in volts (V), when measured under standard conditions: 65 
25°C, 1.0 M, pH 0.0 when in aqueous solution and at a pressure of 100 kPa (0.986 atm) 16. 66 
The reduction potential can be described at non-standard conditions (i.e. physiological 67 
conditions) using the Nernst Equation (Eq. 1), where E is the reduction potential at non-68 
standard conditions, ܧ௢ᇱ is the standard reduction potential at pH 7.0, R is the universal gas 69 
constant (8.3145 J mol−1 K−1), T is the temperature of interest in Kelvin, F is the Faraday 70 
constant (9.6485×104 C mol-1), n is the number of electrons in the reduction reaction and Qr is 71 
the reaction quotient for the half-cell reaction; equal to the ratio of the reduced and oxidised 72 
species: 73 
 ܧ = ܧ௢ᇱ − ܴ ܶ݊ ܨ lnܳ௥ . 
(1) 
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The susceptibility of molecular oxygen to be reduced to O2.- may also be described by its 74 
reduction potential, shown in Equation (2). Specifically, the ability of a semiquinone radical 75 
anion (SQ.-) to reduce molecular oxygen into superoxide can be quantified by linking both 76 
reduction potentials 16.  77 
 ܵܳ.ି + ܱଶ ⇋ ܳ + ܱଶ.ି (2) 
The thermodynamic favourability of the reaction between SQ.- and molecular oxygen can 78 
therefore be assessed by considering ܧ௢ᇱ for the (Q/ SQ.) and (O2/ O2.-), where ܧ௢ᇱ (O2/ O2.-) 79 
is -180 mV 17. The reaction equilibrium constant Keq can also be calculated using Equation 80 
(3): 81 
 ܧ௢ᇲ ൬ ܱଶܱଶ.ି൰ − ܧ
௢ᇲ ൬ ܳܵܳ.ି൰ =
ܴܶ
ܨ lnܭ௘௤. 
(3) 
According to Equation (3), if ܧ௢ᇱ (Q/ SQ.-) is less than ܧ௢ᇱ (O2/O2.-), then the equilibrium will 82 
favour O2.- formation (Equation (2). Similarly, if ܧ௢ᇱ (Q/ SQ.-) is greater than ܧ௢ᇱ (O2/O2.-) 83 
then the opposite is true, favouring the reverse reaction, thereby leaving superoxide formation 84 
thermodynamically unfavourable. However, it is important to recognise that these reactions 85 
are reversible and therefore superoxide formation can occur even if the reverse rate is greater 86 
than the forward rate. Within the cell, the production of superoxide is then a function of other 87 
biological factors that influence the position of the equilibrium, such as, for example, 88 
detoxification by superoxide dismutase enzymes (SOD) 3,18.  89 
The reductive addition reaction between Q and GSH is also linked to reduction potential 90 
(ܧ௢ᇱ), whereby the second order rate constant, dependent on the concentration of the 91 
electrophile and GSH, (log(k/M-1 s-1)) for the Michael reaction may be estimated 3. This is 92 
extremely useful, as it provides a kinetic handle on the non-redox cycling quinone-derived 93 
GSH depletion. Ultimately, toxicity is likely to present when the cellular antioxidant defense 94 
mechanisms, such as glutathione metabolism, are overwhelmed. Indeed, depletion of cellular 95 
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GSH by 20 – 30% of normal has been shown to result in impaired oxidative stress defence 96 
and lead to dell death 19.   97 
In this study, an in silico model of quinone metabolism was used to investigate how redox 98 
cycling-induced ROS production and reductive addition GSH adduct formation impacts 99 
glutathione homeostasis. This work aims to determine the significance of both quinone-based 100 
GSH depletion mechanisms, as well as proposing a mathematical framework that can help 101 
circumvent the experimental difficulty of quantifying reactive radical intermediates in real 102 
time. Using doxorubicin as a training compound, three models of quinone redox cycling were 103 
constructed, each capturing different potential redox cycling mechanisms. Each model was 104 
fitted to oxygen consumption rate data, indicative of ROS formation, allowing the estimation 105 
of unknown kinetic parameters, with the best fit model selected using variance-based 106 
sensitivity analysis, the Akaike Information Criterion (AIC) and Bayesian Information 107 
Criterion (BIC). The selected model was then expanded to include GS-H2Q adduct formation, 108 
estimating the required kinetic formation parameter from its reduction potential, ܧ௢ᇱ, before 109 
being combined with a previously published model of glutathione metabolism. The combined 110 
model was used to simulate the subsequent GSH depletion as a function ROS generated from 111 
redox cycling and adduct formation for a single and extended exposure of doxorubicin.  112 
 113 
Materials and Methods 114 
In silico 115 
Model construction  116 
Three in silico quinone redox metabolism models were proposed, each representing different 117 
potential redox cycling mechanisms (Figure 2). The first model, hereafter referred to as the 118 
reduced model, is a reduced representation describing the cycling between the parent quinone 119 
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(Q) and semiquinone radical anion (SQ.-), as well as superoxide (O2.-) and hydrogen peroxide 120 
(H2O2) formation. The second model (triad model) represents the classical triad of quinone 121 
redox cycling, expanding the reduced model to include the transformation between the 122 
semiquinone radical anion and fully reduced hydroquinone. The third model 123 
(comproportionation model) expands the triad model to include the comproportionation 124 
reaction, whereby two semiquinone radicals can reform the parent quinone compound and 125 
hydroquinone species. A schematic of each model is shown in Figure 2, with the 126 
corresponding kinetic rate equations described in Table 1.  127 
 128 
Model kinetic terms, parameters and initial conditions 129 
Quinone redox reaction kinetics were described according to the law of mass action such that 130 
the rate of reaction is proportional to the concentration of the reactants for a given a rate 131 
constant, with kpn and kmn representing the forward rate and reverse rate constants respectively 132 
and n denotes the considered reaction (1-5; Table 1). Initial-conditions, fitted parameter 133 
values and ordinary differential equations (ODEs) are provided in the supplementary 134 
information. The model ODEs were solved in MATLAB® 2017a via numerical integration 135 
using the variable-order stiff solver ode15s. 136 
 137 
Model selection: AIC-BIC criteria 138 
Model selection was directed using the Akaike Information Criterion (AIC) and Bayesian 139 
Information Criterion (BIC). AIC and BIC values examine how fitted model solutions 140 
compare to the experimental OCR data. Both AIC and BIC values are penalised-likelihood 141 
criterion that consider model complexity (e.g. number of parameter values) and are 142 
commonly used during model selection 20. For example, AIC and BIC values may suggest 143 
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that a less complex model (fewer parameters) may be the most appropriate model to use, even 144 
if a more complex model fits the data better.  145 
GSH metabolism expansion 146 
Expansion of the selected model to include adduct formation (Equation (4)) was achieved by 147 
estimating the reaction rate constant, ݇ொீௌு, from Figure 12 in the work by Song. et al. 3, 148 
using the doxorubicin-specific ܧ௢ᇱ (-292 to -341 mV). This particular figure demonstrates 149 
how the rate constants for the Michael addition of glutathione with various quinones are a 150 
function of the ܧ௢ᇱwith a linear relationship.  151 
 ܳ + ܩܵܪ ௞ೂಸೄಹሱۛ ۛۛሮ ܩܵ-ܪଶܳ. (4) 
Simulating the effects of redox cycling and adduct formation on GSH homeostasis was 152 
achieved by extending the triad quinone metabolism model to include a complete 153 
representation of glutathione metabolism. A full curated version of the GSH metabolism 154 
model developed by Reed et al. 21 was downloaded from the BioModels Database and 155 
amended for simulation and coupling to the quinone metabolism model in MATLAB. 156 
Specifically, the Reed model and quinone redox cycling models were coupled via the H2O2, 157 
Q and GSH variables. Model H2O2 is generated from quinone redox cycling / hydroquinone 158 
auto-oxidation, being detoxified by glutathione peroxidase, and Q and GSH removal is a 159 
function of adduct formation (Michael reaction). The amended ODEs for H2O2, GSH and Q 160 
are as follows: 161 
 162 
 163 
 164 
 165 
 166 
 167 
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 ݀[ܪଶܱଶ]
݀ݐ = 	ܴଷ − ܸீ ௉௫ + ܴ଺,
݀[ܩܵܪ]
݀ݐ = ܸீ ௌ − ௖ܸ௚௦௛ு௕ − ௖ܸ௚௦௛௅௕ − 2	ܸீ ௉௫ + 2	ܸீ ோ − ௚ܸ௦௛ௗ௘௚ − ܴହ,	
݀[ܳ]
݀ݐ = 	−ܴଵ + ܴଶ − ܴହ, 
where, ܴହ = [ܳ][ܩܵܪ]݇ொீௌு and ܴ଺ = [ܱଶ. ି]ଶ݇ௌை஽.  168 
The rate equations for ܸீ ௦, ௖ܸ௚௦௛ு௕, ௖ܸ௚௦௛௅௕, ܸீ ௉௫, ܸீ ோ and ௚ܸ௦௛ௗ௘௚ are taken from Reed et al. 169 
21 and located within the supplementary information, along with the full details of their 170 
model. The successful combination of this model with the redox cycling model was proven 171 
by recapitulation of Figures 2 and 6 from the Reed et al. publication 21, shown in the 172 
supplementary information.  173 
Quinone redox metabolism model assumptions 174 
Like all mathematical models, this biochemical redox cycling model is based upon a set of 175 
assumptions regarding biological and chemical space. The model assumes that the electrons 176 
and factors mediating reductive processes, such as reductase enzymes, are abundant and that 177 
doxorubicin reduction occurs readily. Furthermore, the concomitant rate of auto-oxidation of 178 
doxorubicin within the cell is assumed to be equal to that of the OCR experimental data used 179 
to parameterise the model.  180 
Experimental 181 
Materials 182 
All extracellular flux analysis consumables were purchased from Agilent (North Billerica, 183 
MA, USA). Doxorubicin was purchased from Sigma Aldrich (Dorset, UK).    184 
Extracellular flux analysis (EFA) 185 
The utility plate was calibrated according to manufacturer instructions on the day before the 186 
assay. Doxorubicin stock solution (10 mM, 100 % DMSO) was serially diluted in unbuffered 187 
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seahorse assay medium to prepare 6 concentrations: 400, 300, 200, 100, 80 and 40 µM. 188 
Compound solutions were set to a final pH of 7.0 using HCl and KOH when necessary. Final 189 
compound dilution occurs post-injection giving a final concentration of 50, 35, 25, 12.5, 10 190 
and 5 µM inside the well.  191 
On the day of the assay, doxorubicin working solutions were added to injection port A of 192 
each well of the sensor cartridge (25 µL). The instrument was then calibrated according to the 193 
manufacturer’s instructions. Prior to analysis, the XFe96 instrument (Seahorse Biosciences, 194 
North Billerica, MA, USA) mixed the assay media in each well for 10 minutes to allow the 195 
oxygen partial pressure to reach equilibrium. Extracellular flux analysis was conducted 196 
simultaneously measuring the extracellular acidification rate ECAR via proton production 197 
rate (PPR) and oxygen consumption rate (OCR). The first three measurements were used to 198 
establish a baseline rate. All measurements include a 3-minute mix, allowing the probe to 199 
retract and collapse the transient micro chamber. This allows oxygen tension and pH in the 200 
microenvironment to restore to normal. Doxorubicin was injected after the third measurement 201 
(16 minutes) and the resulting changes in PPR and OCR were measured for a further 20 202 
measurements (over 150 minutes) yielding the basal response.  203 
Results  204 
Experimental  205 
Extracellular flux analysis: oxygen consumption rate (OCR) 206 
Extracellular flux analysis was used to measure the oxygen consumption rate before and after 207 
injection of doxorubicin into unbuffered XF media at pH 7.0 (Figure 3). Doxorubicin (50, 208 
37.5, 25, 12.5 and 10 μM) was injected into the media 16 minutes into the experiment 209 
(between measurements 1 and 2), yielding concentration-dependent oxygen consumption 210 
profiles in a cell-free environment. Oxygen consumption has long been attributed to 211 
hydroquinone auto-oxidation and the formation of H2O2 and O2.- 3,5,22. Auto-oxidation refers 212 
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to oxidation in the absence of a metal catalyst and in this instance, the oxygen consumption 213 
rate data represents doxorubicin hydroquinone (Figure 1b) auto-oxidation 23. Hydroquinone 214 
auto-oxidation yields stoichiometric production of H2O2, shown in Equation (5).  215 
 ܪଶܳ + ܱଶ
௞→ ܪଶܱଶ + ܳ (5) 
 216 
Note, Equation (5) is not intended to describe the complete oxidation mechanisms by which 217 
hydroquinone auto-oxidates to generate H2O2. The actual mechanism is likely to occur via 218 
two sequential steps with semiquinone (SQ.-) and superoxide (O2.-) intermediates. Rather, it 219 
aims to provide concise stoichiometric representation of the formation of H2O2 from H2Q 220 
auto-oxidation. 221 
In silico 222 
Model fitting and selection: AIC BIC Criterion 223 
The oxygen consumption rate (OCR) data generated in Figure 3 provides an experimental 224 
platform for the parameterisation of the mathematical models. The OCR data indirectly 225 
corresponds to H2O2 production, via the superoxide formation reaction shown in Equation 226 
(6). Within the models, the dynamics of O2 are not explicitly specified but rather, assumed to 227 
be constant as ݇ைଶ, due to a separation of scales. Consequently, OCR is then represented by 228 
the R2 reaction flux, as shown in Equation (6).  229 
 ܱܥܴ = ܴଶ = ݇௣ଶ [ܵܳ.ି]݇ைଶ − ݇௠ଶ [ܳ] [ܱଶ.ି]. (6) 
The reduced, triad and comproportionation models were fit to the 37.5 and 25 μM (training 230 
concentrations) OCR data profiles from Figure 3 via the R2 reaction flux shown in Equation 231 
(6). The 50, 12.5 and 10 μM data (test concentrations) were withheld to be used for blind 232 
validation. The unknown rate constants for R1, R2, R3, R4 and R5 for the respective models 233 
were fitted using the LSQNONLIN function in MATLAB, a non-linear least squares solver. 234 
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The performance of each model was compared by examining how close the predicted 235 
solutions were to the experimental OCR data using the penalised-likelihood AIC and BIC 236 
criteria. AIC and BIC values are representative of the distance between the fitted likelihood 237 
of the model and the unknown true likelihood function of the data, with the BIC criterion 238 
penalising model complexity more heavily than the AIC 20,24. Table 2 shows the computed 239 
AIC and BIC values, illustrating that the reduced model returns a much higher score than the 240 
triad and comproportionation models. However, the AIC and BIC values for the triad and 241 
comproportionation models are very similar. Therefore, this criterion was deemed conclusive 242 
enough to discount the reduced model as a viable model for describing the OCR data, but 243 
insufficient to prompt selection of either the triad or comproportionation model.  244 
 245 
Sensitivity analysis: Model selection 246 
Global sensitivity analysis (GSA) was conducted using the classical Sobol method. This 247 
variance-based method is concerned with the decomposition of the output variance and 248 
attributing this variance to input factors 25,26. In this instance, GSA was performed to quantify 249 
the influence of all model parameters on model OCR output (Figure 4), facilitating selection 250 
of either the triad or comproportionation model.  251 
 252 
The results of the global sensitivity analysis for the redox cycling parameters with respect to 253 
model OCR output are shown in Figure 4. Normal distributions were applied to all inputs, 254 
with the mean obtained from the previous optimisation procedure, and coefficient of variation 255 
of 180%. First order main effect indices and the total-order indices were computed. The main 256 
effect indices are equivalent to direct variance-based measures; they measure the effect of 257 
varying an input factor alone, averaged over variations in all other inputs. The total effect 258 
indices provide the contribution of variance in a parameter including the variance of all 259 
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possible higher order interactions, indicating the importance of any input. The use of total 260 
effect indices negates the need for determining higher order interactions which can be 261 
computationally expensive. The sensitivity of the forward rate constants for the superoxide 262 
formation reaction, kp2, and the oxygen concentration parameter, kO2, proved to be the most 263 
sensitive globally with respect to total effects, highlighted in Figure 4. Furthermore, both kp2 264 
and kO2 register as the two most sensitive parameters with respect to the main effects, with kp4 265 
also sensitive. The sensitivity of R4 parameters (kp4) with respect to model OCR output is in 266 
good accordance with the AIC/BIC analysis, confirming the need for the R4 reaction, which is 267 
present in both the triad and the comproportionation models, but not in the reduced model. 268 
This suggests that the reformation of the SQ.- from H2Q is mechanistically important during 269 
the redox metabolism of doxorubicin. 270 
The global sensitivity analysis suggests that the comproportionation reaction, R5, is not 271 
pivotal for the model OCR output, given that its parameters, kp5 and km5, are the two least 272 
sensitive parameters for both main and total interactions. This finding prompted the selection 273 
of the triad model, given that first; R4 is required to adequately model OCR output, illustrated 274 
in both the AIC/BIC analysis and GSA, second; that model OCR output is insensitive to the 275 
inclusion of the comproportionation kinetics (R5) and finally; the triad model is simpler, 276 
requiring estimation of fewer parameters. 277 
Triad model validation 278 
Figure 5 compares the simulated triad model OCR output with the experimental OCR data. 279 
The model was first fitted to the “training concentrations” (37.5 and 25 µM doxorubicin), and 280 
then used to simulate the “test concentrations” (50, 12.5 and 10 µM doxorubicin) as a means 281 
of blind validation, showing good accordance between the experimental and in silico outputs 282 
for all concentrations of doxorubicin. The simulated profiles for the reduced and 283 
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comproportionation models, as well as the parameter values generated from the fitting 284 
process, are located in the supplementary information.  285 
Combined triad-GSH metabolism model simulations: quinone metabolism and ROS 286 
production 287 
Following the parameterisation and sensitivity analysis, the triad model was expanded to 288 
include GS-H2Q adduct formation (quinone removal) and was combined with the glutathione 289 
metabolism model constructed by Reed et al. 21. The combined model output was validated 290 
by replicating Figures 2 and 6 from the Reed et al. publication (shown in the supplementary 291 
information) in order to confirm that; i), the model obtained from the BioModels Database 292 
can recapitulate the figures that were not used for its curation, and ii) that addition of the triad 293 
model does not affect the glutathione metabolism model output when no doxorubicin is 294 
present.  295 
A major benefit of implementing an in silico approach to investigating quinone metabolism is 296 
the ability to simulate and visualise radical species, such as superoxide, in real time, as this is 297 
essentially inaccessible experimentally both in vitro and in vivo. Figure 6 presents the 298 
simulated fate of a single 50 μM doxorubicin exposure (top panel), as well as the subsequent 299 
O2.- and H2O2 profiles, over a 30-minute time-span. The model predicts that a single 50 μM 300 
exposure will yield a rapid but small increase in H2Q and SQ.- of 5.57 μM and 2.10 μM 301 
respectively, with all three forms of the quinone requiring 30 minutes to be removed by GSH 302 
from the system.  303 
 304 
Combined triad-GSH metabolism model simulations: impact of quinone metabolism on 305 
glutathione homeostasis 306 
The model was used to investigate how single vs constant 50 μM exposure of doxorubicin 307 
influenced blood and cytosolic GSH and cysteine (Cys) levels, over a 10-hour time-span, 308 
shown in Figure 7. A single exposure (A) causes a small decrease (less than 3% of normal), 309 
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in both blood and cytosolic GSH and Cys concentrations, with levels returning to above 99% 310 
of normal for all species within the simulated time-span. Cytosolic Cys experiences the 311 
greatest decrease after a single exposure, which is indicative of the model facilitating rapid 312 
GSH re-synthesis after an initial depletion. While cytosolic and blood GSH and Cys 313 
biochemical species all experience depletion, the model predicts that a single exposure to 314 
doxorubicin only results in a minimal perturbation of the antioxidant defence system. In 315 
contrast, a constant 50 μM exposure of quinone (B) overwhelms blood and cytosolic GSH 316 
and Cys, showing no signs of recovery after a 10-hour time-span. Specifically, simulations 317 
suggest that blood Cys and GSH are reduced by 68.7% and 74.1% respectively, whereas 318 
cytosolic Cys and GSH are reduced by 81.2% and 64.6% respectively. While a constant 319 
exposure of quinone is not necessarily representative of an in vivo scenario, it is however, 320 
much more representative of an in vitro situation, whereby a constant source of quinone is 321 
essentially available in the extracellular media during cell culture 27. Therefore, the model 322 
provides a platform from which the impact of varying degrees of quinone concentration and 323 
exposure times on GSH homeostasis may be computationally examined. 324 
A practical application of the combined model would be to predict the concentration and 325 
exposure time required to cause toxicity via overwhelming GSH metabolism as a function of 326 
quinone metabolism. As such, the model was used to simulate how long it would take 327 
pharmacologically and toxicologically relevant concentrations of doxorubicin to yield a 70% 328 
reduction in GSH concentration, indicative of impaired cellular antioxidant defence, protein 329 
binding and cell death 19. 330 
Figure 8 illustrates how a single exposure vs constant infusion of a wide range of doxorubicin 331 
concentrations (0-50 μM) affects cytosolic GSH concentration. The simulation time-span was 332 
extended to 20 hours in order to discern what exposure time and concentration would yield a 333 
70% of normal reduction of GSH. A single exposure of doxorubicin between 0 and 50 μM, 334 
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yields minimal cytosolic GSH depletion (2.5% maximum decrease), which recovers within 335 
the prescribed time-span (Figure 8A). However, for the same concentration range, a constant 336 
exposure can yield a harmful depletion of GSH to 30% of normal after 14 hours, indicated by 337 
the black-dashed line (Figure 8B).  338 
 339 
Discussion 340 
A mathematical modelling approach was deployed to simulate GSH depletion as a function 341 
of doxorubicin redox metabolism. The predominant motivation for mathematically modelling 342 
quinone redox metabolism was to facilitate the investigation of experimentally difficult 343 
scenarios; specifically, the fleeting existence of radical species and the rapid rate at which 344 
redox cycling can generate ROS, causing oxidative stress 5,7,28. Doxorubicin was selected as a 345 
training compound for three reasons: i) the quinone moiety, present in doxorubicin, is 346 
acknowledged as a notorious redox cycler; ii) doxorubicin also contains the hydroquinone 347 
moiety as part of its chemical structure, allowing auto-oxidation to be used as a 348 
parameterisation method for a potential redox cycle; and iii) doxorubicin itself has long been 349 
implicated with futile redox cycling toxicity, specifically within the mitochondria 29.  350 
Mathematically modelling redox cycling is difficult because of the different potential 351 
mechanisms through which the process may occur. However, these difficulties were reduced 352 
by first considering three models (Figure 2), with increasing degrees of mechanistic 353 
complexity, to be aligned with the experimental data. This method allowed the goodness of 354 
fit to inform upon an appropriate model structure when the actual reaction rates were 355 
unknown and, in doing so, provided a useful indication of the possible mechanism by which 356 
this process occurs. Appropriate model assumptions facilitated initial model reduction by 357 
capturing only the essential elements of the system. In this study, it was assumed that using 358 
the auto-reduction of the hydroquinone adjacent to the quinone on doxorubicin was a 359 
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sufficient indicator of the rate of oxidation of a potential redox cycle, either on the 360 
hydroquinone or the quinone after reduction. Indeed, experimental analysis showed that 361 
introduction of doxorubicin into physiologically relevant pH media yielded a concentration-362 
dependent oxygen consumption profile, revealing free (non-metal catalysed) auto-oxidation 363 
(Figure 3). This finding was in good accordance with the literature, where the hydroquinone 364 
is routinely shown to auto-oxidate under these conditions 30,31.  365 
AIC and BIC model selection criteria were deployed to suggest which model is 366 
mechanistically important, guided by the OCR data. The analysis revealed that both the 367 
comproportionation and triad models were better suited to represent the experimental data 368 
than the reduced model, but were inconclusive with respect to overall model selection, given 369 
that both AIC/BIC values were extremely similar (Figure 4). The triad model was selected as 370 
the final model as the comproportionation reaction (R5) parameters (kp5 and km5) were the two 371 
least sensitive parameters with respect to model OCR output for both main and total effects 372 
during global sensitivity analysis (Figure 4). While the comproportionation reaction is a well 373 
reported redox cycling chemical mechanism, in this instance the triad model does not require 374 
the additional comproportionation reaction to accurately replicate the experimental OCR 375 
profile, suggesting that the comproportionation reaction is not mechanistically integral to the 376 
production of ROS through a quinone-based redox cycle. Omission of the 377 
comproportionation kinetics by selecting the triad model also reduces the number of 378 
parameters that require estimating, reducing uncertainty in the overall parameter space.  379 
Global sensitivity analysis revealed that k02 (oxygen concentration) is the most sensitive 380 
parameter for OCR and ROS output, suggesting that biological environments with elevated 381 
oxygen presence could be more susceptible to redox-induced ROS. Indeed, the association of 382 
doxorubicin with bioenergetic toxicity is well stated in the literature 32–34. The global 383 
sensitivity analysis also confirmed the importance of the redox cycle between SQ.- and H2Q 384 
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(R4), showing that the reverse rate constant, km4 (SQ.- reformation), was the second most 385 
sensitive (main interactions) with respect to model OCR and therefore ROS production, 386 
suggesting auto-oxidation is an essential part of the doxorubicin redox mechanism. The triad 387 
model captures the OCR data for all concentrations of doxorubicin, simulating auto-oxidation 388 
via the formation of SQ.- and O2.- intermediates, which is in good accordance with the 389 
literature 3. While the simulations are confined by these assumptions, it is worth noting that 390 
redox cycling is governed by thermodynamics, which according to the reduction potential of 391 
doxorubicin, are favourable with respect to the formation of superoxide should a semiquinone 392 
radical species be present 3. 393 
After the model was expanded to include GS-H2Q adduct formation as a function of its 394 
reduction potential, it was then combined with the Reed glutathione model 21 in order to 395 
simulate how the quinone redox-metabolism of doxorubicin influenced the glutathione 396 
metabolism. The combined model presented here effectively extends the work of Reed et al. 397 
to investigate how quinone redox metabolism can cause toxicity through GSH depletion. The 398 
Reed model provides a comprehensive mathematical representation of one-carbon GSH 399 
metabolism, boasting the inclusion of the transsulfuration pathway, as well as glutathione 400 
synthesis, transport and breakdown. Model curation provides researchers with the ability to 401 
obtain, adapt and implement such mathematical models, as outlined in this study, and is 402 
therefore a powerful tool in the arsenal of any systems biologist, pharmacologist or 403 
toxicologist. The combined model first provided visualisation of quinone redox-metabolism 404 
by capturing the transitions between Q, SQ.- and H2Q, as well as the subsequent production of 405 
O2.- over a 30-minute time-span. Note that semiquinone radicals can possess extremely long 406 
half-lives, up to days at 37°C 35, and as such, it is unsurprising that SQ.- is present over 30 407 
minutes in the model (Figure 6). The simulations suggested that quinone metabolism yielded 408 
an increase in ROS (O2.- and H2O2), producing a maximum of 0.42 μM and 1×10-3 μM 409 
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respectively. Interestingly, despite the presence of superoxide dismutase (SOD) (݇ = 2.4×109 410 
M-1 s-1) 36, the resulting concentration of H2O2 is significantly smaller than the concentration 411 
of superoxide, indicating that the model is able to respond well to a transient increase in ROS, 412 
maintaining low H2O2 concentrations. It is important to note that current in vitro redox 413 
cycling detection is centred on indirect quantification of H2O2 production and O2 414 
consumption rather than direct measurement of dynamic radical species over time 22,28.  415 
The model predicted that for 10-hour-long toxicologically relevant doxorubicin (50 μM) 416 
simulations, the duration of the exposure is more important than concentration with respect to 417 
overwhelming glutathione metabolism. The consideration of cysteine during these 418 
simulations were important, as cytosolic cysteine is the rate limiting amino acid precursor for 419 
synthesis of GSH, via the γ-glutamylcysteine synthetase (GCS) enzyme, and this is a function 420 
of its reduced concentration compared to the other precursors, glycine and glutamate. 421 
Consequently, cysteine availability and the resulting GCS activity are both pivotal for GSH 422 
re-synthesis and therefore provide an indication of the model’s potential to recover GSH 423 
levels 21. 424 
Further simulations showed that over a wide range of doxorubicin (0-50 μM), the model can 425 
be used to suggest the specific concentration and exposure duration required to deplete 426 
cytosolic GSH by 70%, the threshold by which antioxidant defence is impaired, protein 427 
binding occurs, and cell death is possible. A broad range was considered in order to explore 428 
the supra-pharmacological (>10 μM) concentrations required to induce toxicity, as well as the 429 
effects of more pharmacologically relevant values (0.1-1.0 μM) for an extended duration 10. 430 
The influence doxorubicin has on GSH depletion is most certainly also dependent upon the 431 
cell-type and tissue-type in question. For example, lung cancer cell-lines show different 432 
sensitivities to doxorubicin in the form of GSH depletion, with A549 and GLC4210(S) cells 433 
experiencing approximately 50% and 64% GSH depletion after a 12 hour exposure to 70 nM 434 
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and 5 nM (per million cells) respectively 37. However, HeLa cells are much more sensitive, 435 
with 2.5 nM (per million cells) of doxorubicin resulting in up to 80% GSH depletion for the 436 
same exposure time 38. Some cell-types are much less sensitive to doxorubicin-induced GSH 437 
depletion. Hepatocytes treated with 111 μM for 4 hours experience an approximate 20% 438 
decrease in both cytoplasmic and mitochondrial GSH 39. Our model simulations are reflective 439 
of the hepatic GSH environment, agreeing with the supra-pharmacological concentrations of 440 
doxorubicin required to illicit comparable GSH depletion in the liver 39. Indeed, the original 441 
GSH metabolism constructed by Reed et al. explores the properties of glutathione 442 
metabolism in the liver 21, therefore lending confidence to our predictions. Training a 443 
mathematical model to other specific cell-lines is possible and beneficial to reveal phenotypic 444 
heterogeneity in metabolic properties. Such methodology has been successfully applied 40, 445 
and could be implemented in this framework to investigate specific cell and tissue types.  446 
The modelling approach we have utilised in this study facilitates the exploration of potential 447 
toxicity based on a compound’s physicochemical properties, in this instance the reduction 448 
potential. The ability to predict compound concentrations and exposure durations that could 449 
cause a significant compromise in cellular antioxidant defence as a function of a 450 
physicochemical property, especially with respect to an understated mechanism such as redox 451 
cycling, could prove to be extremely useful when investigating toxicity with the reduction of 452 
animal models in mind. In this instance, the concentrations of doxorubicin required to induce 453 
a deleterious GSH response fall firmly outside of the therapeutic ranges of circulating 454 
doxorubicin reported 40. Consequently, simulations suggest that while doxorubicin redox 455 
metabolism impacts GSH metabolism, the concentrations required to illicit a toxic response, 456 
with either a single or extended exposure, reside outside that of the therapeutic dosing range. 457 
This finding agrees with the literature whereby the role of quinone redox metabolism is an 458 
ambiguous source of toxicity, with evidence suggesting that redox cycling requires supra-459 
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pharmacological concentrations of doxorubicin to generate substantial ROS in tissues and 460 
cells 10.  461 
Overall, the combined model demonstrates the utility of high quality previously published 462 
models when constructing a framework to investigate a specific toxicity. The combined 463 
quinone redox – glutathione metabolism model can be used to simulate experimentally 464 
challenging scenarios such as potential redox cycling toxicity, while providing a platform 465 
from which quinone exposure and concentration toxicity experiments may be guided. 466 
Furthermore, the construction of mathematical frameworks such as this can be implemented 467 
to explore other classes of compounds and mechanisms of toxicity as a function of their 468 
physicochemical properties, while providing an alternative method of quantifying 469 
experimentally elusive radical species. 470 
 471 
Data availability 472 
All model parameters and kinetic information are presented in the supplementary 473 
information. Experimental oxygen consumption rate data is provided as an additional file.  474 
 475 
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Figure legends & tables 602 
Figure 1: (a) Quinone redox cycling, ROS formation and GSH-based detoxification. A schematic of the single 603 
electron reduction of a quinone (Q) to a semiquinone radical anion (SQ.-), followed by complete reduction to the 604 
hydroquinone (H2Q). The figure shows the concomitant reduction of molecular oxygen by SQ.- to form the ROS, 605 
superoxide (O2.-), followed by its dismutation into hydrogen peroxide (H2O2), which is detoxified by glutathione 606 
(GSH) into harmless H2O through the glutathione peroxidase (GPx) reaction. GSH is regenerated from its 607 
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oxidised form (GSSG), catalysed by the glutathione reduction (GR) reaction. Finally, the glutathione-quinone 608 
adduct (GS-H2Q) formation represents the reductive addition (Michael reaction) between GSH and the Q 609 
electrophile. (b) Chemical structure of doxorubicin. The anthracycline contains both the quinone (red) and 610 
hydroquinone (blue) moieties within its chemical structure. The hydroquinone is the site of auto-oxidation for 611 
doxorubicin.   612 
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Table 1: Model kinetic expressions. Kinetic terms assembled to describe quinone / doxorubicin redox cycling 613 
are based on the law of mass action. All parameters values were obtained from fitting to experimental data and 614 
are located in the supplementary information. All reactions correspond to Figure 2 only. 615 
Figure 2: Doxorubicin-quinone redox cycling model schematics. Three variations of quinone redox cycling 616 
(reduced, triad and comproportionation) are described. Each model comprises of a single compartment and a 617 
selection of the following species: quinone (Q); semiquinone radical (SQ.-); hydroquinone (H2Q); superoxide 618 
radical (O2.-); molecular oxygen (O2); and hydrogen peroxide (H2O2). The corresponding reaction rate equations 619 
(R1-5) are described in Table 1. 620 
Figure 3: Oxygen consumption rate (OCR) profiles for doxorubicin at 50, 37.5, 25, 12.5 and 10 μM. Each data 621 
point in represents the OCR immediately after a 3-minute solution mix within the well, measured in the transient 622 
microchamber. Compound injection occurs at t = 16 min (between measurements 1 and 2).  Each dataset is the 623 
average of n=3 experiments expressed with its standard deviation. 624 
 Reduced Model 
Triad Model Comproportionation 
Model 
AIC 3.878 × 104 3.239 × 103 3.244 × 103 
BIC 3.879 × 104 3.247 × 103 3.253 × 103 
    
ܴଵ
ܴଷ = ݇௣ଷ	[ܵܳ]ଶ	,
ܴଶ = ݇௣ଶ	[ܵܳ]݇ைଶ
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Table 2: AIC and BIC values for the reduced, triad and comproportionation model fits of the OCR data.   625 
 626 
Figure 4: Normalised sensitivity measures for the comproportionation model reaction rate constants, expressed 627 
as main and total effects. 628 
Figure 5: Triad model fitting and simulation. Comparison of simulated and experimental OCR data for 50, 37.5 629 
25 12.5 and 10 µM of doxorubicin (Figure 3).  630 
Figure 6: Model simulations for doxorubicin and ROS metabolism. The fate of a single doxorubicin exposure 631 
(50 µM) was simulated over a 30-minute time-span in order to glean the resulting transformations between Q, 632 
SQ.- and H2Q (top panel). The resulting superoxide and hydrogen peroxide formation and detoxification profiles 633 
are illustrated in the bottom left and right panels, respectively.  634 
Figure 7: The effects of doxorubicin quinone-based metabolism on glutathione and cysteine model 635 
homeostasis. The resulting simulated changes in blood and cytosolic GSH and cysteine after a single or constant 636 
exposure to 50 μM of doxorubicin are shown in A and B respectively, for a 10-hour time-span. % of normal 637 
represents the percentage difference of the variable compared to its simulated steady state value.  638 
Figure 8: The effects of doxorubicin quinone-based metabolism on glutathione homeostasis. The resulting 639 
simulated changes in cytosolic GSH following single (A) or constant exposure (B) to a range of doxorubicin 640 
concentrations (0-50 μM) are shown in A and B respectively, for a 20-hour time-span. The 70% reduction 641 
threshold is indicated in (B) with a black dashed line. 642 
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